YS Biopharma Co Ltd (YS) Stock Observes 6.70% 200-Day Moving Average

The stock of YS Biopharma Co Ltd (YS) has seen a 33.65% increase in the past week, with a 82.84% gain in the past month, and a 65.03% flourish in the past quarter. The volatility ratio for the week is 14.66%, and the volatility levels for the past 30 days are at 16.22% for YS. The simple moving average for the past 20 days is 25.75% for YS’s stock, with a 6.70% simple moving average for the past 200 days.

Is It Worth Investing in YS Biopharma Co Ltd (NASDAQ: YS) Right Now?

The 36-month beta value for YS is also noteworthy at 0.52. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

The public float for YS is 17.94M, and at present, short sellers hold a 0.65% of that float. The average trading volume of YS on April 04, 2024 was 201.44K shares.

YS) stock’s latest price update

The stock price of YS Biopharma Co Ltd (NASDAQ: YS) has jumped by 12.42 compared to previous close of 0.75. Despite this, the company has seen a gain of 33.65% in its stock price over the last five trading days. InvestorPlace reported 2023-12-19 that While the topic of top penny stocks to buy may arouse controversy similar to apocryphal literature with spiritual implications. That might sound hyperbolic but generally, financial advisors shy away from the sector because of the extreme risks involved.

YS Trading at 62.86% from the 50-Day Moving Average

After a stumble in the market that brought YS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -64.47% of loss for the given period.

Volatility was left at 16.22%, however, over the last 30 days, the volatility rate increased by 14.66%, as shares surge +38.49% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +71.98% upper at present.

During the last 5 trading sessions, YS rose by +33.65%, which changed the moving average for the period of 200-days by -38.99% in comparison to the 20-day moving average, which settled at $0.6813. In addition, YS Biopharma Co Ltd saw 64.77% in overturn over a single year, with a tendency to cut further gains.

Stock Fundamentals for YS

Current profitability levels for the company are sitting at:

  • -0.67 for the present operating margin
  • 0.81 for the gross margin

The net margin for YS Biopharma Co Ltd stands at -0.64. The total capital return value is set at -0.19.

The debt to equity ratio resting at 0.99. The interest coverage ratio of the stock is -12.28.

Currently, EBITDA for the company is -76.82 million with net debt to EBITDA at -1.76. When we switch over and look at the enterprise to sales, we see a ratio of 5.28. The receivables turnover for the company is 0.64for trailing twelve months and the total asset turnover is 0.17. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.41.

Conclusion

In summary, YS Biopharma Co Ltd (YS) has had a better performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts